Literature DB >> 17404249

Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection.

Erica Andersen-Nissen1, Thomas R Hawn, Kelly D Smith, Alex Nachman, Aaron E Lampano, Satoshi Uematsu, Shizuo Akira, Alan Aderem.   

Abstract

Although TLR5 regulates the innate immune response to bacterial flagellin, it is unclear whether its function is essential during in vivo murine infections. To examine this question, we challenged Tlr5(-/-) mice transurethrally with Escherichia coli. At 2 days postinfection, wild-type mice exhibited increased inflammation of the bladder in comparison to Tlr5(-/-) mice. By day 5 postinfection, Tlr5(-/-) mice had significantly more bacteria in the bladders and kidneys in comparison to wild-type mice and showed increased inflammation in both organs. In addition, flagellin induced high levels of cytokine and chemokine expression in the bladder that was dependent on TLR5. Together, these data represent the first evidence that TLR5 regulates the innate immune response in the urinary tract and is essential for an effective murine in vivo immune response to an extracellular pathogen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404249     DOI: 10.4049/jimmunol.178.8.4717

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  77 in total

1.  Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection.

Authors:  Magnus Steigedal; Anne Marstad; Markus Haug; Jan K Damås; Roland K Strong; Pacita L Roberts; Stephanie D Himpsl; Ann Stapleton; Thomas M Hooton; Harry L T Mobley; Thomas R Hawn; Trude H Flo
Journal:  J Immunol       Date:  2014-11-14       Impact factor: 5.422

Review 2.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

Review 3.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

Review 4.  Important aspects of Toll-like receptors, ligands and their signaling pathways.

Authors:  Z L Chang
Journal:  Inflamm Res       Date:  2010-07-01       Impact factor: 4.575

5.  Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection.

Authors:  Natalia Muñoz; Laurye Van Maele; Juan M Marqués; Analía Rial; Jean-Claude Sirard; José A Chabalgoity
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

Review 6.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

Review 7.  The role of Toll-like receptors in renal diseases.

Authors:  Anna Gluba; Maciej Banach; Simon Hannam; Dimitri P Mikhailidis; Agata Sakowicz; Jacek Rysz
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

Review 8.  Genetics of innate immunity and UTI susceptibility.

Authors:  Bryndís Ragnarsdóttir; Nataliya Lutay; Jenny Grönberg-Hernandez; Bela Köves; Catharina Svanborg
Journal:  Nat Rev Urol       Date:  2011-07-12       Impact factor: 14.432

9.  Duplicated TLR5 of zebrafish functions as a heterodimeric receptor.

Authors:  Carlos G P Voogdt; Jaap A Wagenaar; Jos P M van Putten
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-19       Impact factor: 11.205

10.  The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection.

Authors:  Kelsey E Sivick; Matthew A Schaller; Sara N Smith; Harry L T Mobley
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.